Genkyotex SA (GKTX FP)

Genkyotex is a biopharmaceutical company that conducts NOX therapies. The company is listed on the Euronext Paris and Euronext Brussels markets. Genkyotex's therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration.